Impact of Antipsychotic Use on Readmission Rates in Children and Adolescents With Autism Spectrum Disorder and Irritability

Background Risperidone and aripiprazole have been established as standard pharmacological treatments for irritability and associated aggressive behaviors in individuals with autism spectrum disorder (ASD), and are the only drugs approved by the United States Food and Drug Administration for those pu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kompella, Sindhura, Vittori, Angela, Kroin, Jessica, Kaushal, Shivani, Khan, Sara, Neuhut, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934570/
https://www.ncbi.nlm.nih.gov/pubmed/35321066
http://dx.doi.org/10.7759/cureus.22361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934570/
https://www.ncbi.nlm.nih.gov/pubmed/35321066
http://dx.doi.org/10.7759/cureus.22361

Ejemplares similares